Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05336955 · ClinicalTrials.gov registry record · NA
Evaluation of Telehealth Services on Mental Health Outcomes for People With Intellectual and Developmental Disabilities
A NA study of Developmental Disability and Mental Health Conditions, sponsored by University of New Hampshire.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT05336955: Recruiting NA study of Developmental Disability and Mental Health Conditions, sponsored by University of New Hampshire.
NCT05336955 is a NA study of Developmental Disability and Mental Health Conditions that is actively recruiting participants, run by University of New Hampshire. The registered enrollment target is 500 participants, above the 156-participant average among 13 other Developmental Disability trials with a reported enrollment target (221% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05336955, a NA study of Developmental Disability and Mental Health Conditions, is actively recruiting participants, sponsored by University of New Hampshire.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Roughly 40% of those with intellectual and developmental disabilities (IDD) have mental health needs, which is twice the national average. Nevertheless, there is dearth of evidenced-based mental health treatment for youth and young adults with IDD. The disparity in access to mental health care places those with IDD at greater risk of crisis service use. While telemental health studies demonstrate potential to enhance access to care, little of this research includes those with IDD, or crisis prevention and intervention. This project will refine and evaluate telemental health services for youth and young adults with IDD delivered within START (Systemic, Therapeutic, Assessment, Resources, and Treatment), a national, evidence-based model of crisis prevention and intervention for people with IDD. The study will begin with stakeholder feedback (service recipients, families, and providers) regarding telemental health services (Aim 1). Results will be used to refine the intervention. Our team will then compare telemental health versus in-person START services in a randomized control trial (Aim 2). To our knowledge, this will be the first trial of a telemental health crisis program for the IDD population. The final goal is to understand if outcomes vary across subpopulations (Aim 3) and to identify potential disparities. If found, the investigators will work with service users, families and providers to develop a strategy to address identified disparities in outcomes. The study will be executed by an interdisciplinary team of experts engaged with stakeholder partners. Understanding the benefits of specific telemental health methods has important implications to the design of interventions, within and outside of START. This telemental health study offers promise to address disparities in access to mental health care for people with IDD.
Primary Outcome
A semi-structured interview of caregiver experiences with the mental health system
Conditions Studied
Interventions
- OTHER Intake and quarterly assessment:
- OTHER Consultation & coping skills coaching:
- OTHER 24-hour urgent crisis response and intervention:
- OTHER Service linkages, referrals, outreach, & training:
Study Locations (1)
North Carolina
- NC West - Concord
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
What NCT05336955 shows while recruiting
NCT05336955 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 156-participant average among 13 other Developmental Disability trials with a reported enrollment target (221% higher).
The record links to 2 conditions, with Developmental Disability appearing as the primary indexed condition, and to 4 interventions - of which Intake and quarterly assessment: is the first listed.
NCT05336955 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05336955 about?
NCT05336955 is a clinical study titled "Evaluation of Telehealth Services on Mental Health Outcomes for People With Intellectual and Developmental Disabilities". Roughly 40% of those with intellectual and developmental disabilities (IDD) have mental health needs, which is twice the national average. Nevertheless, there is dearth of evidenced-based mental health treatment for youth and young adults with IDD. The disparity in access to mental health care place...
What is the current status of trial NCT05336955?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-05-01. Estimated completion is 2026-11-01.
What conditions does trial NCT05336955 study?
This clinical trial studies the following conditions: Developmental Disability, Mental Health Conditions.
What interventions are being tested in trial NCT05336955?
The interventions under investigation include: Intake and quarterly assessment: (OTHER), Consultation & coping skills coaching: (OTHER), 24-hour urgent crisis response and intervention: (OTHER), Service linkages, referrals, outreach, & training: (OTHER).
Who is sponsoring clinical trial NCT05336955?
This trial is sponsored by University of New Hampshire, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05336955 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Developmental Disability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05336955's enrollment target sits among peer trials
500 2nd of 13 the highest of 13 other Developmental Disability trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Developmental Disability trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Interventions in Mathematics and Cognitive Skills
RECRUITING · NA
-
Online Learning Module to Advance Research Related to People With Disabilities
RECRUITING · NA
-
PRT for Adolescents With High Functioning Autism
RECRUITING · NA
-
Using a Smart Inhaler to Support Asthma Management in Adolescents With Intellectual and Developmental Disabilities
RECRUITING · NA
-
A Center Based Early Intervention Program For Preschoolers With Developmental Disorders
RECRUITING · NA
-
Problem Behavior Assessment and Intervention in IDEA Part C Services
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI